nEDITION nBYnBUTTARO
CLICK nHERE nTO nACCESS nFULL nTEST nBANK
TEST
nBANK
, TEST nBANK nFOR nPRIMARY nCARE n6TH nEDITION nBY
nBUTTARO
Chapter n01: nInterprofessional nCollaborative nPractice: nWhere nWe
nAre nTodaynButtaro: nPrimary nCare: nA nCollaborative nPractice, n6th
nEdition
MULTIPLE nCHOICE
1. A nsmall, nrural nhospital nis npart nof nan nAccountable nCare nOrganization n(ACO)
nand nis ndesignatednas na nLevel n1 nACO. nWhat nis npart nof nthis ndesignation?
a. Bonuses nbased non nachievement nof nbenchmarks
b. Care ncoordination nfor nchronic ndiseases
c. Standards nfor nminimum ncash nreserves
d. Strict nrequirements nfor nfinancial nreporting
ANS: n A
A nLevel n1 nACO nhas nthe nleast namount nof nfinancial nrisk nand nrequirements, nbut
nreceives nsharednsavings nbonuses nbased non nachievement nof nbenchmarks nfor
nquality nmeasures nand nexpenditures. nCare ncoordination nand nminimum ncash
nreserves nstandards nare npart nof nLevel n2 nACO nrequirements. nLevel n3 nACOs
nhave nstrict nrequirements nfor nfinancial nreporting.
2. What nwas nan nimportant nfinding nof nthe nAdvisory nBoard nsurvey nof n2014
nabout nprimary ncarenpreferences nof npatients?
a. Associations nwith narea nhospitals
b. Costs nof nambulatory ncare
c. Ease nof naccess nto ncare
d. The nratio nof nproviders nto npatients
ANS: n C NURSINGTB.COM
As npart nof nthe n2014 nsurvey, nthe nAdvisory nBoard nlearned nthat npatients ndesired
n24/7 naccess ntoncare, nwalk-in nsettings nand nthe nability nto nbe nseen nwithin n30
nminutes, nand ncare nthat nis nclose nto nhome. nAssociations nwith nhospitals, ncosts
nof ncare, nand nthe nratio nof nproviders nto npatients nwerennot npart nof nthese nresults.
MULTIPLE nRESPONSE
1. Which nassessments nof ncare nproviders nare nperformed nas npart nof nthe nvalue-
based npurchasingn(VBP) ninitiative? n(Select nall nthat napply.)
a. Appraising ncosts nper ncase nof ncare nfor nMedicare npatients
b. Assessing npatients’ nsatisfaction nwith nhospital ncare
c. Evaluating navailable nevidence nto nguide nclinical ncare nguidelines
d. Monitoring nmortality nrates nof nall npatients nwith npneumonia
e. Requiring nadvanced nIT nstandards nand nminimum ncash nreserves
ANS: n A, nB, nD
Value-based npurchasing nlooks nat nfive ndomain nareas nof nprocesses nof ncare,
nincluding nefficiencynof ncare n(cost nper ncase), nexperience nof ncare n(patient
nsatisfaction nmeasures), nand noutcomes nof ncare n(mortality nrates nfor ncertain
nconditions). nEvaluation nof nevidence nto nguide nclinical ncare nis npart nof nevidence-
based npractice. nThe nrequirements nfor nIT nstandards nand nfinancial nstatus nare npart
nof nAccountable nCare nOrganization nstandards.
NURSINGTB.COM
, TEST nBANK nFOR nPRIMARY nCARE n6TH nEDITION nBY
nBUTTARO
Chapter n02: nTranslating nResearch ninto nClinical
nPractice nButtaro: nPrimary nCare: nA nCollaborative
nPractice, n6th nEdition
MULTIPLE nCHOICE
1. What nis nthe npurpose nof nLevel nII nresearch?
a. To ndefine ncharacteristics nof ninterest nof ngroups nof npatients
b. To ndemonstrate nthe neffectiveness nof nan nintervention nor ntreatment
c. To ndescribe nrelationships namong ncharacteristics nor nvariables
d. To nevaluate nthe nnature nof nrelationships nbetween ntwo nvariables
ANS: n C
Level nII nresearch nis nconcerned nwith ndescribing nthe nrelationships namong
ncharacteristics nor nvariables. nLevel nI nresearch nis nconducted nto ndefine nthe
ncharacteristics nof ngroups nof npatients.nLevel nII nresearch nevaluates nthe nnature
nof nthe nrelationships nbetween nvariables. nLevel nIV nresearch nis nconducted nto
ndemonstrate nthe neffectiveness nof ninterventions nor ntreatments.
2. Which nis nthe nmost nappropriate nresearch ndesign nfor na nLevel nIII nresearch nstudy?
a. Epidemiological nstudies
b. Experimental ndesign
c. Qualitative nstudies
d. Randomized nclinical ntrials
ANS: n B
The nexperimental ndesign nis nthe nmost nappropriate ndesign nfor na nLevel nIII
nstudy. nEpidemiological nstudies nare naNpU
prR
opSrI
iaN
teGfT
orBL.eC
veOl nM
II nstudies. nQualitative
ndesigns nare nuseful
for nLevel nI nstudies. nRandomized nclinical ntrials nare nused nfor nLevel nIV nstudies.
3. What nis nthe npurpose nof nclinical nresearch ntrials nin nthe nspectrum nof ntranslational
nresearch?
a. Adoption nof ninterventions nand nclinical npractices ninto nroutine nclinical ncare
b. Determination nof nthe nbasis nof ndisease nand nvarious ntreatment noptions
c. Examination nof nsafety nand neffectiveness nof nvarious ninterventions
d. Exploration nof nfundamental nmechanisms nof nbiology, ndisease, nor nbehavior
ANS: n C
Clinical nresearch ntrials nare nconcerned nwith ndetermining nthe nsafety nand
neffectiveness nof ninterventions. nAdoption nof ninterventions nand npractices nis npart
nof nclinical nimplementation. nDetermination nof nthe nbasis nof ndisease nand ntreatment
noptions nis npart nof nthe npreclinical nresearchnphase. nExploration nof nthe
nfundamental nmechanisms nof nbiology, ndisease, nor nbehavior nis npart nof nthe nbasic
nresearch nstage.
NURSINGTB.COM
, TEST nBANK nFOR nPRIMARY nCARE n6TH nEDITION nBY
nBUTTARO
Chapter n03: nEmpowering nPatients nas nCollaborative npartners: nA nNew
nModel nfornPrimary nCare
Buttaro: nPrimary nCare: nA nCollaborative nPractice, n6th nEdition
MULTIPLE nCHOICE
1. Which nstatement nmade nby na nhealth ncare nprovider ndemonstrates nthe
nmost nappropriatenunderstanding nfor nthe ngoal nof na nperformance nreport?
a. “This nprocess nallows nme nto ncritique nthe nperformance nof nthe nrest nof nthe nstaff.”
b. “Most norganizations nrequire nstaff nto nundergo na nperformance nevaluation nyearly.”
c. “It nis nhard nto nbe npersonally ncriticized nbut nthat’s nhow nwe nlearn nto nchange.”
d. “The ncomments nshould nhelp nme nimprove nmy nmanagement nskills.”
ANS: n D
The ngoal nof nthe nperformance nreport nis nto nprovide nguidance nto nstaff nin nthe
nareas nof nprofessional ndevelopment, nmentoring, nand nleadership ndevelopment. nA
npeer nreview nis nwrittennby nothers nwho nperform nsimilar nskills n(peers). nThe
nremaining noptions nmay nbe ntrue nbut ndo nnot nprovide nevidence nof nunderstanding
nof nthe ngoal nof nthis nprofessional nrequirement.
MULTIPLE
nRESPONSE
1. Which nassessment nquestion nwould na nhealth ncare nprovider nask nwhen nengaging
nin nthe nprevisitnstage nof nthe nnew nmodel nfor nprimary ncare? n(Select nall nthat
napply.)
a. “Are nyou nready nto ndiscuss nsome nof nthe ncommunity nresources nthat nare navailable?”
b. “Are nyou nexperiencing nanNyUsid RS
e nI
efN
feGctTs nB
fr.COyM
om our nnewly nprescribed nmedications?”
c. “Do nyou nanticipate nany nproblems nwith nadhering nto nyour ntreatment nplan?”
d. “Are nyou nready nto ndiscuss nthe nresults nof nyour nlaboratory ntests?”
e. “Do nyou nhave nany nquestions nabout nthe nlab ntests nthat nhave nbeen nordered nfor nyou?”
ANS: n B, nC, nE
The nnursing nresponsibilities nin nthe nprevisit nstage ninclude nassessing nthe npatient’s
ntolerance nofnprescribed nmedications, nunderstanding nof nexisting ntreatment nplan,
nand neducation nabout nrequired nlab ntesting. nThe nprimary ncare nprovider nis
nresponsible nfor nscreening nlab ndata nand ndiscussing ncommunity nresources nduring
nthe nactual nvisit.
NURSINGTB.COM